Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS

Journal of Neuroimmunology

Volumn 87, Issue 1-2, 1998, Pages 62-72

  Anthony, D C ^a   Miller, K M ^b   Fearn, S ^a   Townsend, M J ^a   Opdenakker, G ^c   Wells, G M A ^b   Clements, J M ^b   Chandler, S ^b   Gearing, A J H ^b   Perry, V H ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b British Biotech Pharmaceuticals Ltd   (United Kingdom)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Delayed type hypersensitivity; Matrix metalloproteinase; Multiple sclerosis

Indexed keywords

MATRIX METALLOPROTEINASE;

ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE MIGRATION; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BRAIN; CELL MOVEMENT; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; HYPERSENSITIVITY, DELAYED; IMMUNOHISTOCHEMISTRY; INJECTIONS; LEUKOCYTES; MALE; METALLOENDOPEPTIDASES; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED LEW; RNA, MESSENGER;

EID: 0032126878     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00046-0     Document Type: Article

References (35)

1. Anthony, D.C., Bolton, S.J., Fearn, S., Perry, V.H., 1997a. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 120, 435-444.
2. Anthony, D.C., Ferguson, B., Matyzak, M.K., Miller, K.M., Esiri, M.M., Perry, V.H., 1997b. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol. Appl. Neurobiol. 23, 406-415.
3. Calder, V., Owen, S., Watson, C., Feldmann, M., Davison, A., 1989. MS: a localized immune disease of the central nervous system. Immunol. Today 10, 99-103.
4. Cawston, T.E., Galloway, W.A., Mercer, E., Murphy, G., Reynolds, J.J., 1981. Purification of rabbit bone inhibitor of collagenase. Biochem. J. 195, 159-165.
5. Chandler, S., Coates, R., Gearing, A., Lury, J., Wells, G., Bone, E., 1995. Matrix metalloproteinases degrade myelin basic-protein. Neurosci. Lett. 201, 223-226.
6. Clements, J.M., Cossins, J.A., Wells, G.M.A., Corkill, D.J., Helfrich, K., Wood, L.M., Pigott, R., Stabler, G., Ward, G.A., Gearing, A.J.H., Miller, K.M., 1997. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor. J. Neuroimmunol. 74, 85-94.
7. Cuzner, M.L., Gveric, D., Strand, C., Loughlin, A.J., Paemen, L., Opdenakker, G., Newcombe, J., 1996. The expression of tissue-type plasminogen-activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple-sclerosis - comparison of stages in lesion evolution. J. Neuropathol. Exp. Neurol. 55, 1194-1204.
8. Dallman, M.J., Mason, D.W., Webb, M., 1982. The roles of host and donor cells in the rejection of skin allografts by T-cell deprived rats injected with syngeneic T-cells. Eur. J. Immunol. 12, 511-518.
9. Dijkstra, C.D., Dopp, E.A., Joling, P., Kraal, G., 1985. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54, 589-599.
10. Gearing, A.J.H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A.H., Drummond, A.H., Galloway, W.A., Gilbert, R., Gordon, J.L., Leber, T.M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L.M., Wooley, K., 1994. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370, 555-557.
11. Gearing, A.J.H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J.M., Crimmin, M., Davidson, A.H., Drummond, A.H., Galloway, W.A., Gilbert, R., Gordon, J.L., Leber, T.M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., 1995. Matrix metalloproteinases and processing of pro-TNF-alpha. J. Leukocyte Biol. 57, 774-777.
12. Gijbels, K., Galardy, R.E., Steinman, L., 1994. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94, 2177-2182.
13. Halpert, I., Sires, U.I., Roby, J.D., Potterperigo, S., Wight, T.N., Shapiro, S.D., Welgus, H.G., Wickline, S.A., Parks, W.C., 1996. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc. Natl. Acad. Sci. USA 93, 9748-9753.
14. Hewson, A.K., Smith, T., Leonard, J.P., Cuzner, M.L., 1995. Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790. Inflamm. Res. 44, 345-349.
15. Lawson, L.J., Perry, V.H., Dri, P., Gordon, S., 1990. Heterogeneity in the distribution and morphology of microglia in the normal adult-mouse brain. Neuroscience 39, 151-170.
16. Leppert, D., Waubant, E., Galardy, R., Bunnett, N.W., Hauser, S.L., 1995. T cell gelatinases madiate basement membrane transmigration in vitro. J. Immunol. 154, 4379-4389.
17. Leppert, D., Waubant, E., Burk, M.R., Oksenberg, J.R., Hauser, S.L., 1996. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann. Neurol. 40, 846-852.
18. Maeda, A., Sobel, R.A., 1996. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55, 300-309.
19. Matrisian, L.M., 1992. The matrix-degrading metalloproteinases. BioEssays 14, 455-463.
20. Matyszak, M.K., Perry, V.H., 1995. Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette-Guerin. Neuroscience 64, 967-977.
21. Matyszak, M., Perry, V., 1996. Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases. J. Neuroimmunol. 69, 141-149.
22. Matyszak, M.K., Townsend, M.J., Perry, V.H., 1997. Ultrastructural studies of an immune-mediated inflammatory response in the CNS parenchyma directed against a non-CNS antigen. Neuroscience 78, 549-560.
23. Murphy, G., Reynolds, J., 1993. Extracellular matrix degradation. In: Royce, P., Steinmann B., (Eds.), Connective tissue and its Heritable Disorders, Wiley-Liss, New York, pp. 287-316.
24. Murphy, G., Cockett, M.I., Stephens, P.E., Smith, B.J., Docherty, A.J., 1987. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem. J. 248, 265-268.
25. Murphy, G., Cockett, M.I., Ward, R.V., Docherty, A.J., 1991. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277, 277-279.
26. Perry, V.H., Linden, R., 1982. Evidence for dendritic competition in the developing retina. Nature 297, 683-685.
27. Proost, P., Van Damme, J., Opdenakker, G., 1993. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. Biochem. Biophys. Res. Commun. 192, 1175-1181.
28. Romanic, A.M., Madri, J.A., 1994. The induction of 72-kDa gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J. Cell Biol. 125, 1165-1178.
29. Rosenberg, G.A., 1995. Matrix metalloproteinases in brain injury. J. Neurotrauma 12, 833-842.
30. Rosenberg, G.A., Estrada, E.Y., Dencoff, J.E., Stetlerstevenson, W.G., 1995. Tumor necrosis factor-alpha-induced gelatinase-B causes delayed opening of the blood-brain barrier - an expanded therapeutic window. Brain Res. 703, 151-155.
31. Ruoslahti, E., 1996. Brain extracellular-matrix. Glycobiology 6, 489-492.
32. Shapiro, S.D., Kobayashi, D.K., Ley, T.J., 1993. Cloning and characterisation of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268, 23824-23829.
33. Stone, L.A., Frank, J.A., Albert, P.S., Bash, C.N., Calabresi, P.A., Maloni, H., McFarland, H.F., 1997. Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure. Neurology 49, 862-869.
34. Ward, R.V., Hembry, R.M., Reynolds, J.J., Murphy, G., 1991. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Biochem. J. 278, 179-187.
35. Wells, G.M.A., Catlin, G., Cossins, J.A., Mangan, M., Ward, G.A., Miller, K.M., Clements, J.M., 1996. Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard. Glia 18, 332-340.